September 9, 2020 -- LabCorp has launched a combined test for COVID-19, influenza A/B, and respiratory syncytial virus (RSV). The single-panel test is now available throughout the U.S. through doctors, hospitals, and other authorized healthcare providers.
LabCorp said it has also submitted an application to the U.S. Food and Drug Administration to offer the test through its Pixel by LabCorp at-home test collection kit.
When LabPulse gets hot new information, our Insiders are the first to find out. Stay current in today's competitive market by receiving our exclusive free email updates.Yes, Keep Me Current